Legacy Leaders: Dr. Steven Steinhubl
Originally published in PharmaVoice 100
Life Sciences
InCarda, PhysIQ and Syneos team for phase 3 flecainide study
Originally published in Fierce Biotech
Syneos joins with physIQ, InCarda on atrial fibrillation study
Originally published in Outsourcing Pharma
physIQ, InCarda Therapeutics to collaborate on AFib treatment tech
Originally published in MassDevice
Personalized data could bring physIQ to the forefront of clinical trial evolution
Originally published in PharmaVoice
physIQ and CellCarta Collaborate on Personalized Approach to Vaccine Development
Originally published in PharmaTech
physIQ, CellCarta Collaborate on Study to Revolutionize Vaccine
Originally published in HIT Consultant